CD4 and bronchiectasis: Various immunological markers have been proposed to distinguish patients with and without bronchiectasis in CVID: low serum immunoglobulin A and M concentrations at the time of diagnosis, low pre-treatment IgG concentration, and low CD4 count [10, 17, 19, 21] are all factors previously demonstrated to be associated with bronchiectasis in CVID.